UnitedHealth Group's Medicare Advantage network has begun notifying physicians of a new wave of cuts to its network, according to an article published June 17 in Medical Economics.
Minutes and seconds can make a difference in the amount of brain damage suffered by a stroke patient, but now scientists have shown that medication can significantly help limit the damage.
Four steps can be utilized to improve practice productivity, according to an article published June 24 in Medical Economics
People who have genetic variants tied to low production of 25-hydroxyvitamin D (25[OH]D) have an increased risk of hypertension, according to a study published online June 26 in The Lancet Diabetes & Endocrinology.
For patients with ischemic stroke or transient ischemic attack, electrocardiogram (ECG) monitoring with a 30-day event-triggered recorder improves detection of atrial fibrillation, according to a study published June 26 in the New England Journal of Medicine.
Among women with migraines, the frequency of headaches increases during the menopausal transition, according to research presented at the annual meeting of the American Headache Society, held from June 26 to 29 in Los Angeles.
Patients frequently turn to digital media for drug information; however, many Wikipedia entries about medications aren't up-to-date and accurate, according to a perspective piece published in the June 26 issue of the New England Journal of Medicine.
European regulators recently approved alemtuzumab to treat active relapsing-remitting multiple sclerosis, but the US Food and Drug Administration denied the drug for that indication last year.
A new factor in sleep and sleep apnea among obese and overweight men was introduced by researchers at a recent conference, pointing to the man’s testosterone levels as helping determine sleep quality.
Researchers in Saint Louis are examining the ways in which a drug already approved for multiple sclerosis could ease some of the pain associated with chemotherapy for cancer patients.